3rd Quarter - Report

NVG, LLC for PFIZER INC.

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Intellectual property, data exclusivity and patent eligibility, generally; Affordable Prescriptions for Patients Act (S.1416); Affordable Prescriptions for Patients Through Promoting Competition Act (H.R. 4398); Issues related to march-in rights under Bay-Dole Act; Issues related to Patent Trial and Appeal Board.

LobbyistCovered position, as disclosed
JOSHUA F. HURVITZ —
ANDREA LARUE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4398 (116th), S. 1416 (116th)

Health Issues HCR

Prescription drug coverage and payment policies; S. 1872/H.R. 5076, Protecting Seniors Through Immunization Act; Medical innovation issues.

LobbyistCovered position, as disclosed
LISA GERMAN FOSTER —
ANDREA LARUE —
EDEN SHIFERAW —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1872 (116th), H.R. 5076 (116th)

Budget/Appropriations BUD

Issues related to drug supply chain shortages, childhood vaccination coverage disparities under Medicaid and CHIP and shared clinical decision-making for vaccines in the Senate FY 2021 LHHS Appropriations bill and in H.R. 7614, House Fiscal Year Labor, Health and Human Services Appropriations bill.

LobbyistCovered position, as disclosed
IRENE BUENO —
LISA GERMAN FOSTER —
ANDREA LARUE —
JANE LOEWENSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7614 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.